Trial NCT04454567

View at ClinicalTrials.gov 
Org. Study IDs: ABI-H0731-205
Secondary IDs: UTN 1111-1251-7136

Last trial update was posted on 2022-10-20

MeSH Interventions

Reverse Transcriptase Inhibitors

MeSH Conditions

Hepatitis Hepatitis A Hepatitis B Hepatitis B, Chronic Hepatitis, Chronic

Other Conditions

Chronic Hepatitis B

Stopping Reasons

Study stopped due to a change in the Sponsor's overall development strategy from treatment of chronic disease to finite, curative treatments, and is based partially on the advice and feedback from experts and regulators.

Limitations And Caveats

Study ABI-H0731-205 was terminated early by the study Sponsor for strategic reasons to prioritize research and development efforts on finite and curative HBV therapies. At the time of early termination, only 2 participants were enrolled, both of which discontinued their assigned study treatment early due to the study being terminated early by the Sponsor. As a result, the primary outcome of number of participants with HBV DNA

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID